Unveiling the Potential of JAK Inhibitors in Inflammatory Bowel Disease
Background: Janus kinase (JAK) inhibitors represent a novel class of oral therapies showing efficacy in treating ulcerative colitis (UC) and Crohn’s disease (CD), challenging conventional treatment paradigms. Summary: This review provides an overview of the potential novel uses of JAK inhibitors, fo...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2024-05-01
|
| Serija: | Biologics |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2673-8449/4/2/12 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|